PREMAS

Premas is leveraging DCrypt to develop a multicomponent recombinant protein vaccine against COVID-19... Premas Biotech was founded in 2005 with the vision of transforming drug development. We have acquired in-depth expertise and built state-of-the-art technology platforms to provide quality products that are second to none... Premas Biotech is a trendsetter in next generation protein expression process development for scale up; enabling customers steer therapeutic development in a quicker, more certain, secure cost-effective way

Also known as: Premas Biotech

Primary location: Madison United States